Mylan Generic Infringes Endo's Frova Patent, Judge Says
A Delaware federal judge on Tuesday granted Endo Pharmaceuticals Inc. a victory in its patent infringement suit against Mylan Pharmaceuticals Inc., ruling Endo's patent for migraine medication Frova was valid and...To view the full article, register now.
Already a subscriber? Click here to view full article